DexCom, Inc. (DXCM)
61.35
+1.80
(+3.02%)
USD |
NASDAQ |
May 01, 16:00
61.40
+0.05
(+0.08%)
After-Hours: 20:00
DexCom EPS Diluted (Quarterly) : 0.5109 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Insulet Corp. | 1.441 |
| Abbott Laboratories | 0.6165 |
| Intuitive Surgical, Inc. | 2.283 |
| Tandem Diabetes Care, Inc. | -0.0087 |
| Masimo Corp. | 1.311 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 199.50M |
| Revenue (Quarterly) | 1.192B |
| Total Expenses (Quarterly) | 992.40M |
| Enterprise Value | 22.64B |
| Gross Profit Margin (Quarterly) | 66.19% |
| Profit Margin (Quarterly) | 16.74% |
| Earnings Yield | 3.81% |
| Operating Earnings Yield | 4.19% |
| Normalized Earnings Yield | 3.811 |